This article is part of the network’s archive of useful research information. This article is closed to new comments due to inactivity. We welcome new content which can be done by submitting an article for review or take part in discussions in an open topic or submit a blog post to take your discussions online.

This article appears in the Journal of Pharmacology and Pharmacotherapy.

 The citation of this article is:

Bhan A. Clinical trial ethics in India: One step forward, two steps back. J Pharmacol Pharmacother 2012;3:95-7


Excerpt – first paragraph (footnotes excluded)


Clinical trials in India continue to be in the news, unfortunately a fair bit being negative coverage. Over the last few years, there has been continuing outrage on the issue of rising outsourcing of clinical trials to India, with concerns about little benefit or relevance to the public health needs of the country. While this dust has not even settled, allegations of unethical conduct in clinical trials have again brought a focus on the need for regulatory reform and stringent ethical safeguards.

To read the full article, go to:

 This article is freely available through open access.